Article ; Online: LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
European review for medical and pharmacological sciences
2019 Volume 23, Issue 3 Suppl, Page(s) 232–238
Abstract: Objective: To investigate the expression of the long non-coding RNA CADM1-AS1 (lncRNA CADM1-AS1) in gastric cancer and its clinical significance.: Patients and methods: The real time fluorescence quantitative polymerase chain reaction (qRT-PCR) was ... ...
Abstract | Objective: To investigate the expression of the long non-coding RNA CADM1-AS1 (lncRNA CADM1-AS1) in gastric cancer and its clinical significance. Patients and methods: The real time fluorescence quantitative polymerase chain reaction (qRT-PCR) was performed to detect the expression difference of lncRNA CADM1-AS1 between gastric cancer and its adjacent normal tissues. Then, the correlation between the expression of CADM1-AS1 in gastric cancer and the clinicopathological characteristics was analyzed by the Chi-square test. Moreover, the potential of lncRNA CADM1-AS1 in predicting the prognosis of patients with GC after the operation was assessed by the Log-rank test and the Cox's proportional hazards regression model. Results: The expression of lncRNA CADM1-AS1 was significantly decreased in tumor tissues. According to the mean expression of lncRNA CADM1-AS1, the patients were divided into a high expression group and a low expression group, and the expression of lncRNA CADM1-AS1 in gastric cancer was significantly correlated with tumor differentiation, N stage, M stage, and TNM stage. Moreover, the gastric cancer patients with higher expression of lncRNA CADM1-AS1 had a statistically better overall survival (OS) time and progression-free survival (PFS) time. In univariate analyses and multivariate analyses, the expression of lncRNA CADM1-AS1 was an independent prognosis index of patients with gastric cancer. Conclusions: LncRNA CADM1-AS1 might be a new prognostic biomarker for gastric cancer. |
---|---|
MeSH term(s) | Biomarkers, Tumor/genetics ; Down-Regulation ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Neoplasm Staging ; Prognosis ; RNA, Long Noncoding/genetics ; Regression Analysis ; Stomach Neoplasms/genetics ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Survival Analysis |
Chemical Substances | Biomarkers, Tumor ; RNA, Long Noncoding |
Language | English |
Publishing date | 2019-08-05 |
Publishing country | Italy |
Document type | Journal Article |
ZDB-ID | 605550-3 |
ISSN | 2284-0729 ; 1128-3602 ; 0392-291X |
ISSN (online) | 2284-0729 |
ISSN | 1128-3602 ; 0392-291X |
DOI | 10.26355/eurrev_201908_18652 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1887: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.